Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

Symposium highlights: A spotlight on glial cells in MND

Original source

Symposium highlights: A spotlight on glial cells in MNDMotor Neurone Disease Association (UK) · 19 March 2025 (opens in a new tab)

Related topics

Research presented at the 2024 International Symposium on ALS/MND examined how oligodendrocytes, astrocytes and microglia may affect motor neurons. The work included mouse models and lab-grown cells from people with MND-related gene mutations. Findings suggested that glial-cell dysfunction may contribute to motor-neuron damage, but the studies are still investigating mechanisms and possible treatment targets.

Why this matters

This may help researchers understand why motor neurons become damaged in MND and why mutations in the C9orf72 gene can be associated with MND, frontotemporal dementia or both. The work is early and laboratory-based, so it does not currently change treatment for people living with MND.

Limitations and context

This account is an organisational summary of talks at a symposium, not a peer-reviewed primary research paper. Several findings came from mouse models or lab-grown cells, and the source does not provide study sizes, full methods or published results. The proposed therapeutic targets still need to be tested and shown to improve outcomes in relevant models and people.

Summarised by Compass 9 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?